Paper29675604
Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model.
Tada T and 5 others. J Gastroenterol, 2018. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model. Papers, record 29675604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29675604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B, Chronic | Major topic |
| Liver Cirrhosis | Major topic |
| Adult | |
| Age Factors | |
| Aged | |
| Carcinoma, Hepatocellular | |
| Disease Progression | |
| Female | |
| Follow-Up Studies | |
| Hepatitis B Surface Antigens | |
| Hepatitis B e Antigens | |
| Humans | |
| Liver Neoplasms | |
| Male | |
| Markov Chains | |
| Middle Aged | |
| Prognosis | |
| Seroconversion |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6118576 | Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. | Lancet | 1981 | https://conductscience.org/library/papers/6118576 | PubMed |
| 2 | 8246705 | Markov models in medical decision making: a practical guide. | Med Decis Making | 1993 | https://conductscience.org/library/papers/8246705 | PubMed |
| 3 | 212785 | Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. | Prog Med Virol | 1978 | https://conductscience.org/library/papers/212785 | PubMed |
| 4 | 20648555 | A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. | Hepatology | 2010 | https://conductscience.org/library/papers/20648555 | PubMed |
| 5 | 25165830 | The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis. | PLoS One | 2014 | https://conductscience.org/library/papers/25165830 | PubMed |
| 6 | 3294348 | Markov models of natural history. | J Clin Epidemiol | 1988 | https://conductscience.org/library/papers/3294348 | PubMed |
| 7 | 20034030 | Alcoholic liver disease. | Hepatology | 2010 | https://conductscience.org/library/papers/20034030 | PubMed |
| 8 | 18096267 | Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. | J Hepatol | 2008 | https://conductscience.org/library/papers/18096267 | PubMed |
| 9 | 2831148 | Epidemiology of hepatocellular carcinoma. | Gastroenterol Clin North Am | 1987 | https://conductscience.org/library/papers/2831148 | PubMed |
| 10 | 21374666 | Management of hepatocellular carcinoma: an update. | Hepatology | 2011 | https://conductscience.org/library/papers/21374666 | PubMed |
| 11 | 15332272 | Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion. | J Med Virol | 2004 | https://conductscience.org/library/papers/15332272 | PubMed |
| 12 | 20586808 | Clinical Practice Guidelines for Hepatocellular Carcinoma - The Japan Society of Hepatology 2009 update. | Hepatol Res | 2010 | https://conductscience.org/library/papers/20586808 | PubMed |
| 13 | 11576642 | Determination of hepatitis B virus genotype G by polymerase chain reaction with hemi-nested primers. | J Virol Methods | 2001 | https://conductscience.org/library/papers/11576642 | PubMed |
| 14 | 26566064 | AASLD guidelines for treatment of chronic hepatitis B. | Hepatology | 2016 | https://conductscience.org/library/papers/26566064 | PubMed |
| 15 | 19918971 | Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B. | Hepatology | 2010 | https://conductscience.org/library/papers/19918971 | PubMed |
| 16 | 27062182 | Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis. | Liver Int | 2016 | https://conductscience.org/library/papers/27062182 | PubMed |
| 17 | 26201469 | Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. | Hepatol Int | 2012 | https://conductscience.org/library/papers/26201469 | PubMed |
| 18 | 7863398 | Hepatitis viruses and hepatocellular carcinoma. | S Afr Med J | 1994 | https://conductscience.org/library/papers/7863398 | PubMed |
| 19 | 11131465 | Hepatitis B genotypes and the response to interferon therapy. | J Hepatol | 2000 | https://conductscience.org/library/papers/11131465 | PubMed |
| 20 | 27394647 | The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. | Lancet | 2016 | https://conductscience.org/library/papers/27394647 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37580466 | Application and Effectiveness of Chinese Medicine in Regulating Immune Checkpoint Pathways. | Chin J Integr Med | 2023 | https://conductscience.org/library/papers/37580466 | PubMed |
| 37430256 | Establishment of a multi-parameter prediction model for the functional cure of HBeAg-negative chronic hepatitis B patients treated with pegylated interferonα and decision process based on response-guided therapy strategy. | BMC Infect Dis | 2023 | https://conductscience.org/library/papers/37430256 | PubMed |
| 37137846 | [Early antiviral treatment response in HBeAg-positive chronic HBV infected-patients with high viral load and normal ALT]. | Zhonghua Gan Zang Bing Za Zhi | 2023 | https://conductscience.org/library/papers/37137846 | PubMed |
| 37115242 | Monitoring of blood biochemical markers for periprosthetic joint infection using ensemble machine learning and UMAP embedding. | Arch Orthop Trauma Surg | 2023 | https://conductscience.org/library/papers/37115242 | PubMed |
| 36756119 | Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients. | Front Immunol | 2023 | https://conductscience.org/library/papers/36756119 | PubMed |
| 36148219 | Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg. | Front Immunol | 2022 | https://conductscience.org/library/papers/36148219 | PubMed |
| 35958609 | Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients. | Front Immunol | 2022 | https://conductscience.org/library/papers/35958609 | PubMed |
| 35835530 | Multistate Markov model application for blood pressure transition among the Chinese elderly population: a quantitative longitudinal study. | BMJ Open | 2022 | https://conductscience.org/library/papers/35835530 | PubMed |
| 35792921 | Blood pressure states transitions among bus drivers: the application of multi-state Markov model. | Int Arch Occup Environ Health | 2022 | https://conductscience.org/library/papers/35792921 | PubMed |
| 34887645 | Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases. | World J Gastroenterol | 2021 | https://conductscience.org/library/papers/34887645 | PubMed |
| 34869415 | Incidence and Influencing Factors of New Hepatitis B Infections and Spontaneous Clearance: A Large-Scale, Community-Based Study in China. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/34869415 | PubMed |
| 33664363 | The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017. | Sci Rep | 2021 | https://conductscience.org/library/papers/33664363 | PubMed |
| 32974760 | Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same? | J Gastroenterol | 2020 | https://conductscience.org/library/papers/32974760 | PubMed |
| 32185517 | Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review. | J Gastroenterol | 2020 | https://conductscience.org/library/papers/32185517 | PubMed |
| 31318913 | A model of functional thyroid disease status over the lifetime. | PLoS One | 2019 | https://conductscience.org/library/papers/31318913 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29675604
GET https://conductscience.org/api/papers/v1/29675604/references?page=2